WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
142.13
-2.07 (-1.44%)
At close: 4:02PM EDT

142.13 +0.04 (0.03%)
Pre-Market: 8:15AM EDT

Stock chart is not supported by your current browser
Previous Close 144.20
Open 143.43
Bid 142.10 x 900
Ask 142.13 x 900
Day's Range 141.67 - 144.05
52 Week Range 91.75 - 152.10
Volume 362,803
Avg. Volume 310,196
Market Cap 10.581B
Beta (3Y Monthly) 1.31
PE Ratio (TTM) 47.08
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield 0.64 (0.44%)
Ex-Dividend Date 2019-10-22
1y Target Est N/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • West Announces Participation in Upcoming September Investor Conferences
    PR Newswire

    West Announces Participation in Upcoming September Investor Conferences

    EXTON, Pa., Aug. 23, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September. Management will present at the Baird 2019 Global Healthcare Conference in New York, New York on Wednesday, September 4, 2019 and the Morgan Stanley Global Healthcare Conference 2019 in New York, New York on Monday, September 9, 2019. West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.

  • West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
    PR Newswire

    West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend

    - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter ...

  • West to Host Second-Quarter 2019 Conference Call
    PR Newswire

    West to Host Second-Quarter 2019 Conference Call

    EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 6143018. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, August 1, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).

  • West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
    PR Newswire

    West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards

    EXTON, Pa., May 22, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that the NovaGuard® SA Pro safety system – a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes – has won the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design – Shapes and Structures. In addition, the company announced a new product line extension to its AccelTRA® component program, and showcased thought leadership with presentations at the UBM InnoPack Pharma Conference in Mumbai. The prestigious India Packaging Awards, presented on May 21, 2019 during a ceremony held at the Sahara Star Hotel, are an initiative by UBM to honor the best innovations in the Pharma Packaging space.

  • West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
    PR Newswire

    West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences

    EXTON, Pa., May 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share. The Company also announced that management will present an overview of the business at three investor conferences in May and June. A live audio webcast of the presentations and a copy of the presentation materials will be accessible from the Company's website at www.westpharma.com/en/investors.

  • West Announces First-Quarter 2019 Results
    PR Newswire

    West Announces First-Quarter 2019 Results

    - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter ...

  • West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
    PR Newswire

    West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree

    EXTON, Pa., April 12, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient. West received the honor for its ongoing support of Fox Chase Cancer Center during an awards breakfast on April 11, 2019. Organized by the Philadelphia Business Journal, the Faces of Philanthropy awards recognize Philadelphia-based companies who, through philanthropic initiatives with a non-profit organization, have made a large impact on the Philadelphia community through monetary donations, social impact and community involvement.

  • West to Host First-Quarter 2019 Conference Call
    PR Newswire

    West to Host First-Quarter 2019 Conference Call

    EXTON, Pa., April 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 7794502. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, May 2, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406  (International).

  • West Expands Presence in Korea with New Sales Office
    PR Newswire

    West Expands Presence in Korea with New Sales Office

    SEOUL, South Korea, April 4, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West Pharmaceutical Services Korea Ltd. This new office is the result of West's purchase of the distribution business of GIS Korea Ltd., a privately-owned medical device and healthcare products distributor serving the Korean market, who previously served as West's distributor in the region. "We are excited to build upon the strong foundation that our distributor has established in Korea, as this is an important market for West and our customers," said Karen Flynn, Senior Vice President and Chief Commercial Officer, West.

  • West Opens New Digital Technology Center in Bengaluru, India
    PR Newswire

    West Opens New Digital Technology Center in Bengaluru, India

    BENGALURU, India, March 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India, a regional hub of digital and technology talent. This state-of-the-art business space will serve as a global center of excellence for the Company's Digital and Transformation (D&T) team, alongside teams based in Exton, Pennsylvania, and Eschweiler, Germany.

  • GlobeNewswire

    Detailed Research: Economic Perspectives on The J. M. Smucker, West Pharmaceutical Services, Franklin Electric Co., Accenture, LiveXLive Media, and Otter Tail — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • West Announces Quarterly Dividend and Share Repurchase Program
    PR Newswire

    West Announces Quarterly Dividend and Share Repurchase Program

    EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per ...

  • West Announces Fourth-Quarter and Full-Year 2018 Results
    PR Newswire

    West Announces Fourth-Quarter and Full-Year 2018 Results

    - Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter ...

  • West to Host Fourth-Quarter and Full-Year 2018 Conference Call
    PR Newswire

    West to Host Fourth-Quarter and Full-Year 2018 Conference Call

    EXTON, Pa., Jan. 31, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday, February 14, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 2287302. An online archive of the broadcast will be available at the West website three hours after the live call and through Thursday, February 21, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).

  • West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
    PR Newswire

    West Announces Quarterly Dividend and Participation in Upcoming Investor Conference

    EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per ...

  • GlobeNewswire

    Consolidated Research: 2018 Summary Expectations for Aquinox Pharmaceuticals, Xilinx, West Pharmaceutical Services, nVent Electric, World Wrestling Entertainment, and HD Supply — Fundamental Analysis, Key Performance Indications

    NEW YORK, Nov. 01, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • West Announces Participation in Upcoming November Investor Conferences
    PR Newswire

    West Announces Participation in Upcoming November Investor Conferences

    EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management ...

  • West Announces Third-Quarter 2018 Results
    PR Newswire

    West Announces Third-Quarter 2018 Results

    - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter ...

  • West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
    PR Newswire

    West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide

    EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award. The honor was presented to West on October 9, 2018, at the CPhI Worldwide conference in Madrid, Spain. Organized by CPhI Worldwide, one of the world's largest pharma trade shows, the CPhI Pharma Awards recognize innovative pharmaceutical companies who are committed to driving the industry forward.

  • West to Host Third-Quarter 2018 Conference Call
    PR Newswire

    West to Host Third-Quarter 2018 Conference Call

    EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 8341499.

  • West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
    PR Newswire

    West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events

    West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, ...

  • West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
    PR Newswire

    West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award

    EXTON, Pa., Sept. 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green, has received the CEO Connection's 2018 Social Impact Award. The honor was presented to Mr. Green at the CEO Connection's Mid-Market Convention Awards Dinner on September 25, 2018, at the University of Pennsylvania Museum of Archaeology and Anthropology, located in Philadelphia, Pennsylvania.